ANA/RF combination | Negative HCV-IgG | Positive HCV-IgG | Bilateral P value |
N = 306 | N = 74 | ||
ANA and RF | 94 (31 %) | 29 (39 %) | <0.001 |
Isolated ANA | 200 (65 %) | 32 (43 %) | |
Isolated RF | 12 (4 %) | 13 (18 %) | |
Ro/La combination | Negative HCV-IgG | Positive HCV-IgG | Bilateral P value |
N = 314 | N = 21 | ||
Anti-Ro and anti-La antibodies | 178 (57 %) | 12 (57 %) | 0.014 |
Isolated anti-Ro antibodies | 114 (36 %) | 4 (19 %) | |
Isolated anti-La antibodies | 22 (7 %) | 5 (24 %) | |
Cryoglobulinemic-related markers combination | Negative HCV-IgG | Positive HCV-IgG | Bilateral P value |
N = 38 | N = 60 | ||
Cryoglobulins+RF+low C4 | 7 (18 %) | 28 (47 %) | 0.019 |
Cryoglobulins+RF | 12 (32 %) | 13 (22 %) | |
Cryoglobulins+low C4 | 6 (16 %) | 10 (17 %) | |
Isolated cryoglobulins | 13 (34 %) | 9 (15 %) |